Secondary laboratory recurrence after radical prostatectomy: Multivariate analysis of clinical, laboratory and histological prognostic factors;Récidive biologique secondaire après prostatectomie radicale : Analyse multivariée des facteurs pronostiques cliniques, biologiques et histologiques

Progres en Urologie

Volumn 11, Issue 2, 2001, Pages 277-282

  Malavaud, Bernard ^a   Game, Xavier ^a   Villers, Arnauld ^a   Mouzin, Marc ^a   Mazerolles, Catherine ^b   Rischmann, Pascal ^a   Sarramon, Jean Pierre ^a  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

Cancer; Prognostic factors; Prostate; Radical prostatectomy; Recurrence

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; AGED; ARTICLE; BLOOD; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; PROSTATE TUMOR; PROSTATECTOMY; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 3042896651     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. ABBAS F., KATTAN M.W., WHEELER T.M., ADLER H.L., SCARDINO P.T. : Survival and cancer control for patients with T1-T2 prostate cancer with the intent to treat by radical prostatectomy. J. Urol., 1998, 159, 252 (abstract 964).
2. BADALAMENT R.A., MILLER M.C., PELLER P.A., YOUNG D.C., BARNS D.K., KOCHIE P., O'DOWD G., VELTRI R.W. : An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostatic specific antigen levels. J. Urol., 1996, 156, 1375-1380.
3. BLUTE M.L., NATIV O., ZINCKE H., FARROW G.M., THERNEAU T., LIEBER M.M. : Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate : influence of tumor deoxyribonucleic acid ploidy. J. Urol., 1989, 142, 1262-1265.
4. CATALONA W.J., SMITH D.S. : Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer : intermediate-term results. J. Urol., 1998, 160, 2428-2434.
5. CHEMASLE C., MALAVAUD B., RISCHMANN P., MAZEROLLES C., BALLANGER P., SARRAMON J.P. : How to predict the occurrence of positive resection margins and the secondary rise of PSA after radical prostatectomy. Proceedings of the XIth Congress of European Association of Urology, Berlin, 1994, p. 329.
6. DILLIOGLUGIL O., LEIBMAN B.D., KATTAN M.W., SEALEHAWKINS C., WHEELER T.M., SCARDINO P.T. : Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology, 1997, 50, 93-99.
7. EPSTEIN J.I., CARMICHAEL M., PARTIN A.W., WALSH P.C. : Is tumor volume an independant predictor of progression following radical prostatectomy. A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow-up. J. Urol., 1993, 149, 1478-1481.
8. EPSTEIN J.I., PIZOV G., WALSH P. : Correlation of pathologic findings with progression with progression following radical retropubic prostatectomy. Cancer, 1993, 71, 3582-3593.
9. FESSEHA T., SAKR W., GRIGNON D., BANERJE M., WOOD D.P., PONTES J.E. : Prognostic implications of a positive apical margin in radical prostatectomy specimens. J. Urol., 1997, 158, 2176-2179.
10. FRAZIER H.A., ROBERTSON J., HUMPHREY P.A., PAULSON D.F. : Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. J. Urol., 1993, 149, 516-518.
11. GERBER G.S., THISTED R.A., SCARDINO P.T. FROHMULLER H.G., SCHROEDER F.H., PAULSON D.F., MIDDLETON A.W., RUKSTALIS D.B., SMITH J.A., SCHELLHAMMER P.F., OHORI M., CHODAK G.W. : Results of radical prostatectomy in men with clinically localized prostate cancer : multi-institutional pooled analysis. JAMA, 1996, 276, 615-619.
12. GETTMAN M.T., BERGSTRALH E.J., BLUTE M., ZINCKE H., BOSTWICK D.G. : Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate : lack of significance for microvessel density analysis. Urology, 1998, 51, 79-85.
13. LANGE P.H., ERCOLE C.J., LIGHTNER D.J., FRALEY E.E., VESSELLA R. : The value of serum prostate specific antigen determinations before and after radical prostatectomy. J. Urol., 1989, 141, 873-879.
14. LERNER S.E., BLUTE M.L., BERGSTRALH E.J., BOSTWICK D.G., EICKHOLT J.T., ZINCKE H. : Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J. Urol., 1996, 156, 137-143.
15. MALAVAUD B., MAZEROLLES C., RISCHMANN P., BERTRAND N., SARRAMON J.P. : Evolution des indications et des résultats histologiques et biologiques de la prostatectomie radicale. Prog. Urol., 1999, 9, 668-671.
16. MARECHAL J.M. : La prostatectomie radicale résultats et perspectives, Rapport du 88ème Congrès de L'association française d'Urologie, Prog. Urol., 1994, 4, 729-917.
17. MIDDLETON R.G., THOMPSON I.M., AUSTENFELD M.S., COONER V.H., CORREA R.J., GIBBONS R.P., MILLER H.C., OESTERLING J.E., RESNICK M.I., SMALLEY S.R. : Prostate Cancer Clinical Guidelines Panel summary report on the management of clinically localized prostate cancer. J. Urol., 1995, 154, 2144-2148.
18. MONTIE J.E. : Current prognostic factors for prostate carcinoma. Cancer, 1996, 78, 341-344.
19. OEFELEIN M.G., GRAYHACK J.T., Mc VARY K.T. : Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate. Cancer, 1995, 76, 2535-2542.
20. PARTIN A.W., POUND C.R., CLEMENS J.Q., EPSTEIN J.I., WALSH P.C. : Serum PSA after anatomic radical prostatectomy. Urol. Clin. N. Amer., 1993, 20, 713-725.
21. POUND C.R., PARTIN A.W., EISENBERGER M.A., CHAN D.W., PEARSON J.D., WALSH P.C.: Natural history of progression after PSA elevation following radical prostatectomy. J.A.M.A., 1999, 281, 1591-1597.
22. POUND C.R., PARTIN A.W., EPSTEIN J.I., WALSH P.C. : Prostate-specific antigen after anatomic radical prostatectomy. Urol. Clin. N. Amer., 1997, 24, 395-406.
23. RAVERY V., BOCCON-GIBOD L.A., DAUGE-GEFFROY M.C., DELMAS V., MEULEMANS A., TOUBLANC M., BOCCON-GIBOD L. : Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology, 1994, 44, 371-376.
24. STAMEY T.A., FREIHA F.S., Mc NEAL J.E., REDWINE E.A., WHITEMORE A.S., SCHMIDT H.P. : Localized prostate cancer, Cancer, 1993, 71, 933-938.
25. STAMEY T.A., Mc NEAL J.E., YEMOTO C.M., SIGAL B.M., JOHNSTONE I.M. : Biological determinants of cancer progression in men with prostate cancer. J.A.M.A., 1999, 281, 1395-1400.
26. STAMEY T.A., YEMOTO C.M., Mc NEAL J.E., SIGAL B.M., JOHNSTONE I.M. : Prostate cancer is highly predictable : a prognostic equation based on all morphological variables in radical prostatectomy specimens. J. Urol., 2000, 163, 1155-1160.
27. VALLANCIEN G., BOCHEREAU G., WETZEL O., BRETHEAU D., PRAPOTNIC D., BOUGARAN J. : Influence of preoperative positive seminal vesicle biopsy to the staging of prostatic cancer. J. Urol., 1994, 152, 1152-1156.